Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cassia nomame is an annual herb from the pea family (Leguminosae) traditionally used in East Asian medicine and consumed as tea. The pharmaceutical form is typically an extract from the above-ground parts of the plant. Chemically, it contains flavone derivatives (flavonoids), chalcone and aurone derivatives, anthraquinones, phenolic compounds, and sterol derivatives[2]. Its principal pharmacological effect is **inhibition of intestinal lipase activity**, leading to reduced dietary fat absorption and, accordingly, potential **weight loss**[7][4][5][10]. The extract also has **antioxidant properties** (radical scavenging) and has demonstrated reduction of oxidative stress and cellular injury in animal models, including myocardial ischemia-reperfusion[3][2]. Traditional uses include constipation, diuretic effects (increasing urine output), reduction of swelling, and general tonic for health/wellness[4][7][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cassia nomame.